Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine for Endothelial Function in Type 2 Diabetes
NCT00446810Phase 4Unknown
- Sponsor
- Ruhr University Bochum
- Start
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Benfotiamine with Placebo (2 arms). Primary endpoint: Endothelial function (flow mediated dilatation and reactive hyperemia) at 6 weeks. Status: unknown.
02
Drugs
benfotiamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00446810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446810.